Clinical validation of an immunochromatographic SARS-Cov-2 IgM/IgG antibody assay with Japanese cohort.

Shun KanekoYoko NukuiTakeshi ArashiroYoshibumi AisoMaya SugiiYoshiro HadanoKaoru NagataReiko TakiKen UedaSatoko HanadaShinichiro SuzakiNaoshige HaradaYoshimi YamaguchiHiroyuki NakanishiMasayuki KurosakiMasayuki NagasawaNamiki Izumi

Published in: Journal of medical virology (2020)

The SARS-Cov-2 IgM/IgG Ab assay had 79.7% / 86.1% sensitivity (the 8 days after from onset) and 100% specificity in this population.

Keyphrases

sars cov
high throughput
respiratory syndrome coronavirus